Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04004156
Other study ID # N181
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date June 30, 2022

Study information

Verified date July 2021
Source Spinal Stabilization Technologies
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.


Description:

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device (NRD). The NRD is used for surgical replacement of a single nucleus pulposus between spinal lumbar discs L1-S1 using an anterior or lateral transpsoas approach. Currently the surgical gold standard involves spinal fusion of the affected vertebral bodies, reducing range of motion and increasing stress on other vertebral bodies. The goal of nucleus replacement is to reduce chronic low back pain by maintaining disc height while preserving range of motion.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 9
Est. completion date June 30, 2022
Est. primary completion date January 31, 2022
Accepts healthy volunteers No
Gender All
Age group 22 Years to 60 Years
Eligibility Inclusion Criteria: - Patient is skeletally mature and between 22 and 60 years of age. - Patient has degenerative disc disease (DDD) at a single level between L1 and S1 as confirmed by:History and clinical findings suggestive of symptomatic DDD, Darkened disc on MRI in T2 weighted images, and decreased disc height (decreased greater than 2 mm compared to adjacent cranial or caudal disc height) with minimum disc height of 6 mm. - Patient has pre-operative back pain VAS score of greater than or equal to 4 (0-10 scale). - Patient has pre-operative Oswestry Low Back Disability score of greater than or equal to 40 (0-100 scale). - Patient has received conservative (non-surgical) treatment for back pain for a minimum of 6 months. - Patient has signed the approved Informed Consent Form. Exclusion Criteria: - Patient has had prior lumbar spine surgery. - Patient has motion of less than 3 degrees on pre-operative lateral flexion/extension radiographs. - Patient has ankylosing spondylitis or other spondyloarthropathy. - Patient has isthmic spondylolisthesis or degenerative spondylolisthesis greater than 2 mm. - Patient has congenital stenosis or epidural lipomatosis. - Patient has significant facet disease. - Patient has any known active malignancy. - Patient has previously undergone immunosuppressive therapy. - Patient has active local or system infection. - Patient has been diagnosed with hepatitis, rheumatoid arthritis, lupus erythematosus, or other autoimmune disease, including AIDS, ARC and HIV - Patient has diabetes mellitus (Type 1 or 2), requiring daily insulin management. - Patient has osteopenia of the spine (T-score less than 1.0). All females 45 years of age or older and all males 50 or older should have a DEXA scan to confirm this exclusion. - Patient has morbid obesity defined as body mass index (BMI) more than 40 or a weight of more than 45 kg (100 lbs) over ideal body weight. - Patient is pregnant or plans to become pregnant during the course of the study. - Patient has a known allergy to silicone (polymer and balloon material) or barium sulfate (polymer). - Patient participated in another investigational drug or device study within the past 30 days. - Patient belongs to a vulnerable population or has a condition such that his/her ability to provide informed consent, comply with follow-up requirements, or provide self assessments is compromised (e.g. developmentally disables, prisoner, chronic alcohol/ substance abuser) - Patient has a disc herniation - Patient has a Schmorl's node in the level to be treated Intraoperative exclusion criteria: - Protrusion of the 20A imaging balloon up to or beyond the outer margin of the vertebra during the imaging steps. - Patient has a violated endplate. - Patient has a disc space that is too narrow.

Study Design


Intervention

Device:
PerQdisc® Nucleus Replacement Device.
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.

Locations

Country Name City State
Belgium Onze Lieve Vrouw Ziekenhuis Aalst
Canada Montreal General Hospital Montreal Quebec
Croatia Clinical Hospital Dubrava Zagreb
Germany Donauisar Klinikum Deggendorf Deggendorf

Sponsors (1)

Lead Sponsor Collaborator
Spinal Stabilization Technologies

Countries where clinical trial is conducted

Belgium,  Canada,  Croatia,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of revision surgery at the treated level Number of patients requiring surgeries to revise the implanted level in the spine divided by the total number of implant surgeries. Express in percentage (0-100) 90 days
Primary Rate of expulsion The rate of device expulsion. The number of patients determined to have expulsed devices divided by the total number of patients receiving implants.Expressed in percentage (0-100) 90 Days
Primary Rate of new herniation at the treated level as determined by MRI Herniation will be determine by MRI. A herniation will be defined as violation of the intervertebral annulus, including expulsion of nucleus material. The response will be yes/no as assessed by the radiologist. Rate will be determined by total number of herniations divided by the total number of implanted devices. Expressed in percentage (0-100) 90 days
Primary Rate of new radiculopathy New complaint of leg pain will be recorded as a yes/no response. Any complaint of new radiculopathy not seen preoperatively. Expressed as total number of new radiculopathy complaints divided by total number of patients. Expressed in percentage (0-100) 90 days
Primary MRI assessment of the endplate Modic changes. Changes to vertebral endplates will be assigned based on Modic classification of I,II or III comparing preoperative grade to grade at 90 days. Possible scores are I,II or III 90 days
Primary Rate of surgical procedure technical success The number of devices successfully implanted divided by the number of successfully devices implanted + unsuccessful implants. Output will be in percentage (0-100) 90 days
Primary Improvement in degree of disability as measured by the Oswestry Disability Index (ODI) Change in absolute Oswestry Index score at 90 days compared to the preoperative score, range is 0-100 90 days
Primary Improvement in back pain as measured by 10-centimeter Visual Analog Scale (VAS) Change in the Visual Analogue Scale (VAS) for back and leg pain on a scale of 0-10 cm comparing preoperative scores to 90 days post-operative. 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Active, not recruiting NCT05114135 - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study) N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Withdrawn NCT03223701 - Efficacy of Using Solum IV and BMC With GFC in TLIF Phase 4
Completed NCT04057235 - Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
Not yet recruiting NCT06000319 - Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Active, not recruiting NCT02969616 - Trinity Elite in Lumbar Fusion
Completed NCT02558621 - New Robotic Assistance System for Spinal Fusion Surgery N/A
Completed NCT02104167 - Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
Completed NCT00996073 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion Phase 2
Completed NCT00965380 - Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Completed NCT00758719 - Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
Completed NCT00165893 - Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease Phase 4
Terminated NCT01494493 - Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04849429 - Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain Phase 1
Recruiting NCT04469387 - Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion N/A
Recruiting NCT04056520 - Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
Completed NCT04119466 - Stabilizing Training in Degenerative Disc Disease N/A